MedPath

a clinical trial to study the effects of three drugs, dexmedetomedine, ketamine and tramadol for prevention of shivering under spinal anaesthesia

Phase 4
Conditions
Health Condition 1: M179- Osteoarthritis of knee, unspecified
Registration Number
CTRI/2020/12/029892
Lead Sponsor
Dr Tanwin Khan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Patientâ??s undergoing elective surgery under spinal anaesthesia and with valid consent

ASA-1 and 2

Age 18-65 yrs

Height â?? 140- 180cms

Lower limb surgeries

Lower abdominal surgeries

Exclusion Criteria

Patient refusal

ASA- 3 & 4

Age < 18yrs & > 65yrs

Drug allergy

Compromised cardio- respiratory functions

Renal or hepatic disease

Thyroid disorders

Psychiatric disorder

Severe diabetes or autonomic neuropathies

Known history of substance or alcohol abuse

Pregnant patients

Obese (body mass index >30kg/m2)

Contraindications to spinal anaesthesia

Patients having visual analogue scale (VAS) >6 intra-operatively and were offered general anaesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All the drugs i.e, dexmedetomedine, ketamine and tramadol decrease the shivering under spinal anesthesia compared to normal saline in their lowest possible doses used <br/ ><br> <br/ ><br>Timepoint: wrench shivering grades 1 and 2 are managed conservatively and grades 3 and 4 are treated with pethidine <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
side effects of drugs dexmedetomidine(sedation), ketamine(increased arterial blood pressure) and tramadol(nausea and vomitings) are studiedTimepoint: sedation is assessed with filos grading and grade 3 and 4 are considered positive
© Copyright 2025. All Rights Reserved by MedPath